Results 181 to 190 of about 4,732,777 (361)
ABSTRACT Background Although prophylactic broad‐spectrum antibiotics can reduce postoperative complications after pancreaticoduodenectomy (PD), the optimal regimen remains uncertain. This study evaluated the impact of prophylactic cefepime (CFPM) on surgical site infection (SSI) and severe morbidity after PD with preoperative biliary drainage.
Genki Watanabe +8 more
wiley +1 more source
Impact of Frailty on the Outcomes of Patients with Pancreatic Cancer Undergoing Neoadjuvant Therapy. [PDF]
Williams NR +9 more
europepmc +1 more source
Neoadjuvant Therapy Should Be the Standard of Care for Every Node Positive Breast Cancer Patient [PDF]
Omar Hamdy
openalex +1 more source
This systematic review and meta‐analysis of 38 studies, encompassing over 5000 patients, compared extralevator abdominoperineal excision (ELAPE) with standard abdominoperineal excision (APE) in patients with advanced low rectal cancer. ELAPE was associated with significantly improved overall and disease‐free survival, reduced intraoperative perforation
Sarolta Beáta Kávási +7 more
wiley +1 more source
Survival Outcomes in Patients With Locally Advanced NSCLC Converted to Resectable Disease by Neoadjuvant Therapy. [PDF]
Gulsen ED +7 more
europepmc +1 more source
ABSTRACT Aim To examine the significance of portal vein tumor thrombus (PVTT) as a prognostic factor for patients with pancreatic ductal adenocarcinoma (PDAC) treated with chemoradiotherapy (CRT) followed by surgery. Methods The study retrospectively examined 313 patients with borderline resectable (BR) or locally advanced (LA) PDAC who underwent CRT ...
Aoi Hayasaki +9 more
wiley +1 more source
Research trends in neoadjuvant therapy for esophageal cancer: a bibliometric and meta-analysis. [PDF]
Wang H, Zhang J, Yang J, Chang H.
europepmc +1 more source
This study introduces a framework that combines graph neural networks with causal inference to forecast recurrence and uncover the clinical and pathological factors driving it. It further provides interpretability, validates risk factors via counterfactual and interventional analyses, and offers evidence‐based insights for treatment planning ...
Jubair Ahmed +3 more
wiley +1 more source
Neoadjuvant therapy with cadonilimab in a patient with MSI-H/dMMR colorectal cancer: a case report. [PDF]
Zhou J +6 more
europepmc +1 more source

